Close

Endocyte (ECYT) Reports Supply Agreement with ITM for EndolucinBeta in Phase 3 VISION Trial

February 26, 2018 11:47 AM EST Send to a Friend
Endocyte, Inc. (NASDAQ Global Market: ECYT), and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login